<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01751321</url>
  </required_header>
  <id_info>
    <org_study_id>40591</org_study_id>
    <nct_id>NCT01751321</nct_id>
  </id_info>
  <brief_title>Glucose Variability With DPP-4 Inhibition</brief_title>
  <official_title>Glucose Variability With DPP-4 Inhibition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Research Clinical Centre of the Russian Railways, JSC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Research Clinical Centre of the Russian Railways, JSC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glucose Variability With DPP-4 Inhibition
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Type 2 Diabetes, age 35-75y., will be included in this double blind randomized
      placebo controlled study.

      The sample size of 50 patients completing the 30 day study period is based on statistical
      input from Merck Research Laboratories, Rahway NJ.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glucose variability</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>sitagliptin, metformin, placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>group- 25 patients will take sitagliptin 50 mg and metformin 1000 mg twice in a day
group- 25 patients will take placebo 50 mg and metformin 1000 mg twice in a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sitagliptin, placebo</intervention_name>
    <description>sitagliptin 50 / metformin 1000 twice in a day and placebo 50 mg /metformin 1000 twice in a day</description>
    <arm_group_label>sitagliptin, metformin, placebo</arm_group_label>
    <other_name>Januvia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  receiving a stable dose of metformin â‰¥ 1500 mg

          -  HbA1c 7,5% -10/0 %

        Exclusion Criteria:

          -  Type 1 diabetes

          -  HbA1c &lt; 7,5% and &gt; 10,0%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Ametov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Clinical Centre of the Russian Railways, JSC</affiliation>
  </overall_official>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2012</study_first_submitted>
  <study_first_submitted_qc>December 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2012</study_first_posted>
  <last_update_submitted>December 13, 2012</last_update_submitted>
  <last_update_submitted_qc>December 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Sitagliptin Phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

